HDGF and cancer: To the best of our knowledge, this is the first report of an adaptive protein complex formation mechanism that affects resistance to MAPKi in cancer cells, so it is important to characterize the protein interaction interfaces between HDGF and LGR5 in future studies to develop potential drugs to block the formation of the HDGF-LGR5 protein complex.